Dept of Otolaryngology, South Infirmary Victoria University Hospital, Cork, Ireland.
Dept of Otolaryngology, South Infirmary Victoria University Hospital, Cork, Ireland; ENTO Research Unit, College of Medicine and Health, University College Cork, Ireland.
Oral Oncol. 2022 Apr;127:105797. doi: 10.1016/j.oraloncology.2022.105797. Epub 2022 Mar 7.
Pathological margin assessment is an essential component of surgical management of oral cavity squamous cell carcinoma (OCSCC), however, in many studies, variable definitions of involved margins have been used. The purpose of the present study was to compare the prognostic ability of involved margins according to Royal College of Pathologists (RCPath) and College of American Pathologists (CAP) guidance.
Retrospective study of 300 patients with previously untreated OCSCC undergoing definitive surgical management. Main specimen margin status was defined according to RCPath guidance and CAP guidance. "Final margin status", incorporated the results of frozen sections and extra tumour bed resections. The prognostic impact of each margin definition was studied using univariate analysis, and in multivariate models including T-stage (AJCC 8th edition), nodal status (pN+), extranodal extension (ENE), and use of adjuvant radiotherapy.
Both RCPath and CAP positive margins were associated with local recurrence (LR), disease-specific survival (DSS), and overall survival (OS) on univariate analysis, while final margin status was associated with LR and DSS, but not OS. On multivariate analysis, only CAP positive main specimen margin status was independently associated with LR (odds ratio 2.44, 95% CI 1.37, 4.34), DSS (odds ratio 2.28, 95% CI 1.31, 3.82), and OS (odds ratio 1.59, 95% CI 1.04, 2.42).
Involved main specimen margin as defined by CAP guidance has the advantage of being an independent prognosticator of LR and survival in our cohort.
病理边缘评估是口腔鳞状细胞癌(OCSCC)手术治疗的重要组成部分,然而,在许多研究中,使用了不同的边缘受累定义。本研究的目的是比较根据皇家病理学院(RCPath)和美国病理学家学院(CAP)指南确定的受累边缘的预后能力。
对 300 例接受确定性手术治疗的初治 OCSCC 患者进行回顾性研究。主要标本边缘状态根据 RCPath 指南和 CAP 指南定义。“最终边缘状态”纳入了冷冻切片和额外肿瘤床切除的结果。使用单因素分析和包括 T 分期(第 8 版 AJCC)、淋巴结状态(pN+)、结外扩展(ENE)和辅助放疗使用的多因素模型研究每种边缘定义的预后影响。
RCPath 和 CAP 阳性边缘均与局部复发(LR)、疾病特异性生存(DSS)和总生存(OS)相关,而最终边缘状态与 LR 和 DSS 相关,但与 OS 无关。多因素分析显示,仅 CAP 阳性主要标本边缘状态与 LR(优势比 2.44,95%CI 1.37,4.34)、DSS(优势比 2.28,95%CI 1.31,3.82)和 OS(优势比 1.59,95%CI 1.04,2.42)独立相关。
在我们的队列中,CAP 指南定义的受累主要标本边缘具有 LR 和生存的独立预后预测价值的优势。